Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Mandibular Neoplasms × Clear all

Phase

Status

Completed 4 Unknown 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1576 Neoplasms 1072 Colorectal Neoplasms 893 Carcinoma, Non-Small-Cell Lung 868 Stomach Neoplasms 690 Carcinoma, Hepatocellular 687 Lung Neoplasms 651 Prostatic Neoplasms 598 Pancreatic Neoplasms 487 Rectal Neoplasms 374 Neoplasm Metastasis 359 Ovarian Neoplasms 348 Colonic Neoplasms 345 Recurrence 334 Uterine Cervical Neoplasms 331 Leukemia, Myeloid, Acute 324 Esophageal Neoplasms 293 Multiple Myeloma 290 Lymphoma 281 Head and Neck Neoplasms 281 Melanoma 270 Brain Neoplasms 236 Precursor Cell Lymphoblastic Leukemia-Lymphoma 230 Urinary Bladder Neoplasms 222 Nasopharyngeal Carcinoma 194 Lymphoma, Large B-Cell, Diffuse 193 Leukemia 191 Liver Neoplasms 183 Polycystic Ovary Syndrome 175 Squamous Cell Carcinoma of Head and Neck 173

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03678467 2022-05-27

EB-CMF

Epibone, Inc.

Phase 1/2 Unknown

Congenital Abnormalities, Mandibular Injuries, Mandibular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡